BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer Anthony Gonçalvès , Marine Gilabert , E. François +16 more 2012 Annals of Oncology 211 citations